Abiopharma

🔍 Cable Thomas J. (Director)

Company: OMEROS CORP (OMER)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 7,500 shares of Common Stock at $2.0 per share (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 42,567.00 | transaction_form_type: 4
• Acquired 7,500 shares of Common Stock at $3.93 per share (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 50,067.00 | transaction_form_type: 4
• Sold 15,000 shares of Common Stock at $18.4515 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 35,067.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 7,500 shares of Stock Option (Right to Buy) at $2.0 per share (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2032-06-17 | Exercise: 2023-06-22 | equity_swap_involved: 0 | transaction_form_type: 4
• Sold 7,500 shares of Stock Option (Right to Buy) at $3.93 per share (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2032-09-21 | Exercise: 2023-06-22 | equity_swap_involved: 0 | transaction_form_type: 4

Footnotes:

• F1: This transaction was executed in multiple trades at prices ranging from $18.23 to $18.72. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.